Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2017, Article ID 6738095, 5 pages
https://doi.org/10.1155/2017/6738095
Research Article

Molecular Epidemiology of Rifampicin Resistance in Mycobacterium tuberculosis Using the GeneXpert MTB/RIF Assay from a Rural Setting in India

1Department of Microbiology, Rural Development Trust Hospital, Bathalapalli, Andhra Pradesh, India
2Department of Infectious Diseases, Rural Development Trust Hospital, Bathalapalli, Andhra Pradesh, India

Correspondence should be addressed to Gerardo Alvarez-Uria; moc.liamg@airuodrareg

Received 29 August 2017; Revised 28 September 2017; Accepted 11 October 2017; Published 26 October 2017

Academic Editor: James Chambers

Copyright © 2017 Raghuprakash Reddy and Gerardo Alvarez-Uria. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Companion Handbook to The WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis, 2014, http://www.ncbi.nlm.nih.gov/books/NBK247420/.
  2. World Health Organization, Global tuberculosis report 2016, 2016, http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf.
  3. S. D. Lawn and M. P. Nicol, “Xpert MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance,” Future Microbiology, vol. 6, no. 9, pp. 1067–1082, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Office of the Registrar General and Census Commissioner, Census of India, India, 2011.
  5. T. Bodmer and A. Ströhle, “Diagnosing pulmonary tuberculosis with the Xpert MTB/RIF test,” Journal of Visualized Experiments, no. 62, Article ID e3547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Raizada, K. S. Sachdeva, A. Sreenivas et al., “Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in india,” PLoS ONE, vol. 9, no. 2, Article ID e89301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Agresti and B. A. Coull, “Approximate is better than "exact" for interval estimation of binomial proportions,” The American Statistician, vol. 52, no. 2, pp. 119–126, 1998. View at Publisher · View at Google Scholar · View at MathSciNet
  8. A. Rahman, M. Sahrin, S. Afrin et al., “Comparison of Xpert MTB/RIF assay and genotype MTBDRplus DNA probes for detection of mutations associated with rifampicin resistance in mycobacterium tuberculosis,” PLoS ONE, vol. 11, no. 4, Article ID 0152694, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Kaur, N. Jindal, S. Arora, and S. Kataria, “Epidemiology of rifampicin resistant tuberculosis and common mutations in rpoB gene of Mycobacterium tuberculosis: a retrospective study from six districts of Punjab (India) using Xpert MTB/RIF assay,” Journal of Laboratory Physicians, vol. 8, no. 2, pp. 96–100, 2016. View at Publisher · View at Google Scholar
  10. E. A. Ochang, U. A. Udoh, U. E. Emanghe et al., “Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria,” International Journal of Mycobacteriology, vol. 5, pp. S145–S146, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Mboowa, C. Namaganda, and W. Ssengooba, “Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study,” BMC Infectious Diseases, vol. 14, article 481, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Ullah, A. A. Shah, A. Basit et al., “Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study,” BMC Infectious Diseases, vol. 16, article 413, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Z. Metcalfe, S. Makumbirofa, B. Makamure et al., “XpertW MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe,” The International Journal of Tuberculosis and Lung Disease, vol. 20, no. 7, pp. 882–889, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Agizew, R. Boyd, N. Ndwapi et al., “Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: experience gained from a pragmatic, stepped-wedge trial in Botswana,” PLoS ONE, vol. 12, no. 8, p. e0183237, 2017. View at Publisher · View at Google Scholar
  15. J. Creswell, A. J. Codlin, E. Andre et al., “Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries,” BMC Infectious Diseases, vol. 14, article 2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Alvarez-Uria, J. M. Azcona, M. Midde, P. K. Naik, S. Reddy, and R. Reddy, “Reddy R. rapid diagnosis of pulmonary and extrapulmonary tuberculosis in hiv-infected patients. comparison of LED fluorescent microscopy and the genexpert MTB/RIF assay in a district hospital in India,” Tuberculosis Research and Treatment, vol. 2012, 4 pages, 2012. View at Publisher · View at Google Scholar
  17. G. Theron, L. Zijenah, D. Chanda et al., “Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial,” The Lancet, vol. 383, no. 9915, pp. 424–435, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Thirumurugan, M. Kathirvel, K. Vallayyachari, K. Surendar, A. V. Samrot, and M. Muthaiah, “Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India,” Journal of Infection and Public Health, vol. 8, no. 6, pp. 619–625, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. U. B. Singh, P. Pandey, G. Mehta et al., “Genotypic, phenotypic and clinical validation of genexpert in extra-pulmonary and pulmonary tuberculosis in India,” PLoS ONE, vol. 11, no. 2, Article ID e0149258, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Suresh, U. B. Singh, J. Arora et al., “rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India,” Infection, Genetics and Evolution, vol. 6, no. 6, pp. 474–483, 2006. View at Publisher · View at Google Scholar · View at Scopus